Hyperglycemia and the fate of apparent diffusion coefficient - Defined ischemic penumbra

American Journal of Neuroradiology

Volumn 32, Issue 5, 2011, Pages 852-856

  Rosso, Charlotte ^a,b   Attal, Y ^a,b   Deltour, S ^a   Hevia Montiel, N ^a,b   Lehericy S ^a,b   Crozier, S ^a   Dormont, D ^a,b   Baillet, S ^a,b   Samson, Y ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MIDDLE CEREBRAL ARTERY; MULTIPLE REGRESSION; STROKE;

AGED; BRAIN ISCHEMIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STROKE;

EID: 79956105568     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2407     Document Type: Article

References (36)

1. Bruno A, Levine SR, Frankel MR, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002;59:669-74
2. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001;32:2426-32
3. Leigh R, Zaidat OO, Suri MF, et al. Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy. Stroke 2004;35:1903-07
4. Fuentes B, Castillo J, San José B, et al. The prognostic value of capillary glucose levels in acute stroke. The GLycemia in Acute Stroke (GLIAS) study. Stroke 2009;40:562-68
5. Hamilton MG, Tranmer BI, and Auer RN. Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg 1995;82:262-68
6. Pulsinelli WA, Waldman S, Rawlinson D, et al. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology 1982;32:1239-46
7. Rehncrona S, Rosén I, and Siesjö BK. Brain lactic acidosis and ischemic cell damage: 1. Biochemistry and neurophysiology. J Cereb Blood Flow Metab 1981;1:297-311
8. Alvarez-Sabín J, Molina CA, Ribó M, et al. Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. Stroke 2004;35:2493-98
9. Baird TA, Parsons MW, Phanh T, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003;34:2208-14
10. Parsons MW, Barber PA, Desmond PM, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002;52:20-28
11. Ribo M, Molina CA, Delgado P, et al. Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with rtPa. J Cereb Blood Flow Metab 2007;27:1616-22
12. Neumann-Haefelin T, Wittsack HJ, Wenserski F, et al. Diffusion- and perfusion- weighted MRI. The DWI/PWI mismatch region in acute stroke. Stroke 1999;30:1591-97
13. Grandin CB, Duprez TP, Smith AM, et al. Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. Radiology 2002;223:361-70
14. Parsons MW, Yang Q, Barber PA, et al. Perfusion magnetic resonance imaging maps in hyperacute stroke: relative cerebral blood flow most accurately identifies tissue destined to infarct. Stroke 2001;32:1581-87
15. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508-17
16. Montiel NH, Rosso C, Chupin N, et al. Automatic prediction of infarct growth in acute ischemic stroke from MR apparent diffusion coefficient maps. Acad Radiol 2008;15:77-83
17. Hevia-Montiel N, Rosso C, Chupin M, et al. Automatic prediction of final infarct growth in acute ischemic stroke from MR apparent diffusion coefficient maps. Int J Comp Assist Radiol Surg 2006;1:115-17
18. Rosso C, Hevia-Montiel N, Deltour S, et al. Prediction of infarct growth based on apparent diffusion coefficients: penumbral assessment without intravenous contrast material. Radiology 2009;250:184-92
19. Detre JA, Zager EL, Alsop DC, et al. Correlation of diffusion MRI and heat shock protein in a rat embolic stroke model. J Neurol Sci 1997;148:163-69
20. Na DG, Thijs VN, Albers GW, et al. Diffusion-weighted MR imaging in acute ischemia: value of apparent diffusion coefficient and signal intensity thresholds in predicting tissue at risk and final infarct size. AJNR Am J Neuroradiol 2004;25:1331-36
21. Oppenheim C, Grandin C, Samson Y, et al. Is there an apparent diffusion coefficient threshold in predicting tissue viability in hyperacute stroke? Stroke 2001;32:2486-91
22. Sakoh M, Ostergaard L, Gjedde A, et al. Prediction of tissue survival after middle cerebral artery occlusion based on changes in the apparent diffusion of water. J Neurosurg 2001;95:450-58
23. Schaefer PW, Ozsunar Y, He J, et al. Assessing tissue viability with MR diffusion and perfusion imaging. AJNR Am J Neuroradiol 2003;24:436-43
24. Neumann-Haefelin T, du Mesnil de Rochemont R, Fiebach JB, et al. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke 2004;35:109-14
25. Luby M, Bykowski JL, Schellinger PD, et al. Intra- and interrater reliability of ischemic lesion volume measurements on diffusion-weighted, mean transit time and fluid-attenuated inversion recovery MRI. Stroke 2006;37:2951-56
26. Stead LG, Gilmore RM, Arnand N, et al. Interventions for controlling hyperglycaemia in acute ischemic stroke. (Protocol) Cochrane Database of Systematic Reviews 2005; Issue 3. Art. No.: CD005346. DOI:10.1002/14651858. CD005346
27. McCormick MT, Muir KW, Gray CS, et al. Management of hyperglycemia in acute stroke: how, when, and for whom? Stroke 2008;39:2177-85
28. Samson Y, Bruandet M, Lejeune M, et al. Insulin in the treatment of ischemic stroke. Presse Med 2006;35:696-98
29. Gray CS, Hildreth AJ, Sandercock PA, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007;6:397-406
30. Kent TA, Soukup VM, and Fabian RH. Heterogeneity affecting outcome from acute stroke therapy: making reperfusion worse. Stroke 2001;32:2318-27
31. Bruno A, Saha C, Williams LS, et al. IV insulin during acute cerebral infarction in diabetic patients. Neurology 2004;62:1441-42
32. Klijn CJ, Hankey GJ, and American Stroke Association and European Stroke Initiative. Management of acute ischaemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative. Lancet Neurol 2003;2:698-701
33. Kreisel SH, Berschin UM, Hammes HP, et al. Pragmatic management of hyperglycaemia in acute ischaemic stroke: safety and feasibility of intensive intravenous insulin treatment. Cerebrovasc Dis 2008;27:167-75
34. Scott JF, Robinson GM, French JM, et al. Blood pressure response to glucose potassium insulin therapy in patients with acute stroke with mild to moderate hyperglycaemia. J Neurol Neurosurg Psychiatry 2001;70:401-04
35. MR Stroke Collaborative Group, Phan TG, Donnan GA, et al. Proof-of-principle phase II MRI studies in stroke: sample size estimates from dichotomous and continuous data. Stroke 2006;37:2521-25
36. Warach S. Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials. Curr Control Trials Cardiovasc Med 2001;2:38-44